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Abstract Exposure of weanling rats to a diet containing the 
element tellurium results in specific inhibition of squalene 
epoxidase, an obligate enzyme in cholesterol biosynthesis. 
Liver responds to the resulting intracellular sterol deficit by 
up-regulating, in parallel and to the same extent, expression 
of mRNA for squalene epoxidase and for HMCXoA reduc- 
tase, the major rate-limiting enzyme in the pathway. This in- 
creased riiRNA expression, coupled with additional transla- 
tional and posttranslational activation of the pathway, allows 
normal levels of cholesterol synthesis in  liver despite tellu- 
rium-indiiced inhibition of squalene epoxidase. The response 
to tellurium challenge in sciatic nene is very different. I n  this 
tissue, cholesterol synthesis is prominent because of the large 
amount of cholesterol required for synthesis and mainte- 
nance of myelin. Although nerve shows an initial (at 1 day) 
up-regulation of mRNA expression for both enzymes in re- 
sponse to tellurium exposure, this is followed quickly by paral- 
lel down-regulation of both enzymes, in concert with down- 
regulation of mRNA expression for myelin proteins.a We 
suggest that the tellurium-induced deficit in sterols leads t o  ;I 
coordinate down-regulation of synthesis of inyelin compo- 
nents. The initial early up-regulation of cholesterol biosynthe- 
sis in sriatic nerve due to the cholesterol deficit is countered 
by down-regulation which is coordinated with overall control 
of  the program of myelin assembly. This tissue-specific control 
of cholesterol synthesis in sciatic nervr is a point ofvulnerahil- 
ity to toxicants, and may be rrlated to the need for coordinate 
synthesis of all components of'~nvelin.-Toews, A. D., H. Jure- 
vics, J. Hostettler, E. B. Roe, and P. Morell. Tissue-specitic 
coordinate regulation of  enzymes of cholesterol biosynthesis: 
tic nerve versiis liver. ,/. 1,ipid Rrr. ISS6. 37: 2502-2509. 
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A compound may be considered a "neurotoxicant" 
if its adverse effects, although possibly present on a sys- 
temic basis, are disproportionately apparent as damage 
to the central o r  peripheral nervous systems. Presun- 
ably, some metabolic process preferentially relevant to 
nervous system function is targeted. This may involve a 
toxic action on neurons and/or  their processes. How- 
ever, most cells of the nervous system are glial cells, and 
these can be preferential targets for neurotoxicants :is 
well, with resulting insults also leading to nervous sys- 
tem dysfunction (see ref. 1 for review). In the periph- 
eral nervous system (PNS), Schwann cells are the glial 
cells responsible for synthesis and maintenance of my- 
elin, the compact multilamellar extension of the 
Schwann cell plasma membrane required for efficient 
and rapid impulse conduction in axons. 
Inclusion of tellurium (element #52) in the diet 01 
weanling rats leads to rapid inhibition of the synthesis 
of cholesterol ( 2 )  by specifically blocking squalene 
epoxidase ( 3 ,  4) ,  an obligate enzyme in the cholesterol 
biosynthetic pathway. Although inhibition of this en- 
zyme by a metabolite of tellurium is systemic, the 
Schwann cell-myelin unit of the PNS is prefkrentially 
affected by this insult (see ref. 5 for review). This It&- 
flects the quantitative significance of cholesterol in  PNS 
myelin, which requires that its synthesis be especially 
prominent during the period of rapid PNS myelin accii- 
niulation occurring immediately following weaning. 
The block in the synthesis of cholesterol, a niolectile 
required for formation and maintenance of a stable niy- 
elin structure, leads to a highly synchronous demyelin- 
ation of up  to one-fourth of tlic myelin internodes i n  
sciatic nerve. This demyelination, in turn, results in ;I 
peripheral neuropathy characterized by hindlimb pare- 
sis and paralysis. M'he11 telltirium cxposui-c. is discon- 
tinued, there is rdpitl and synchronous re~iiyelinatioii, 
with consequent recovery of normal neurological fiinc- 
tion. 
Despite inhibition of squalene epoxidase by tellii- 
rium, il normal lcvel of circulating cholesterol is maiii- 
lained. That under these conditions the sciatic nen~r 
deniyelinates suggests that the PNS cannot utilize this 
Ahbrrviations: H M ( X o A ,  hydl-osy~ne~liyl~lutaryl-cocii/~~r~e A; 
PNS, periptienrl ~ i e ~ w i i i s  system; LDL,, low density lipoprorcin; IYX,  
polpinerase chain reaction; SRE, sterol regulatory element. 
'To whwii cor-resptrndcncr ;ind rcprint rrqiwstt" shoctltl bc. XI- 
ti rrsscci. 
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circulating cholesterol, an hypothesis which we have 
verified (6). How does liver maintain circulating choles- 
terol levels in the face of inhibition of the biosynthetic 
pathway? We (7) have shown that in sciatic nerve, ex- 
pression of mRNA for both HMGCoA reductase, the 
major rate-limiting enzyme in cholesterol biosynthesis, 
and for myelin proteins is down-regulated in parallel. 
We interpret this as down-regulation of the program for 
synthesis and assembly of myelin components, second- 
ary to the tellurium-induced deficit in required cho- 
lesterol. This is in contrast to liver, which responds to 
tellurium challenge by up-regulation of HMGCoA re- 
ductase. The latter response is as expected from knowl- 
edge of the well-Characterized regulatory mechanism in- 
volving intracellular sterol levels and the LDL-receptor 
(see refs. 8-10 for review). We have now examined in 
more detail these differences in tissue-specific re- 
sponses to tellurium challenge. Of interest was whether 
the difference in response of liver and sciatic nerve was 
specific for HMGCoA reductase, or whether squalene 
epoxidase, another key enzyme of cholesterol biosyn- 
thesis located subsequent to reactions in the pathway 
that provide isoprenoid units, was coordinately con- 
trolled with HMGCoA reductase. In addition, we were 
able to assay in vivo synthesis of cholesterol in these tis- 
sues. Correlation of this parameter with levels of mRNA 
for the two enzymes of interest gives insight into organ- 




All animal use procedures were in accordance with 
the NIH Guide for the Care and Use of Laboratq Animals 
and were approved by the University of North Carolina 
Institutional Animal Care and Use Committee. At 20 
days of age, male Sprague-Dawley rats were placed on 
a diet containing 1.5% elemental tellurium powder (60 
mesh, Aldrich, Milwaukee, WI) in milled Purina rodent 
chow (very low cholesterol content), with 12% (w/w) 
corn oil added to prevent separation of the mixture 
(1 1) .  Control animals were maintained on the same 
milled rodent chow plus corn oil, but without tellurium. 
Exposure to tellurium was continued for 7 days, after 
which all rats were placed on regular pelleted rodent 
chow ad lib. Rats were killed at times ranging from 1 
to 30 days following beginning of the 7-day tellurium 
exposure period. Sciatic nerves and a 30-50-mg sample 
of liver were removed, quickly frozen on dry ice, and 
stored at -80°C until RNA was isolated. 
The procedure €or sciatic nerve transection was as de- 
scribed previously (12). Rats were anesthetized with ket- 
amine and xylazine and subjected to unilateral transec- 
tion of the sciatic nerve at the level of the sciatic notch. 
The proximal portion of the nerve was sutured into an 
adjacent muscle to inhibit axonal regeneration. At 
times ranging from 1 to 10 days after nerve transection, 
the distal stumps were removed, quickly frozen on dry 
ice, and stored at -80°C until RNA was isolated. 
RNA isolation and Northern blot analyses 
Total RNA was isolated from frozen nerve and liver 
samples by homogenization in guanidine isothiocya- 
nate and purified by centrifugation through cesium 
chloride and subsequent ethanol precipitation (13; see 
also 1 1). RNA species were separated according to mo- 
lecular weight on denaturing 0.8% agarose gels con- 
taining formaldehyde (14) and transferred to Zeta- 
Probe nylon blotting membranes (Bio-Rad Labora- 
tories, Richmond, CA). Filters were hybridized with '"P- 
labeled cDNA probes, synthesized using either double- 
stranded polymerase chain reaction (PCR) methodol- 
ogy (15) for amplification of squalene epoxidase cDNA 
(1 6), or single-stranded PCR methodology (17) for 
HMGCoA reductase (18) and P,, (19) cDNA. Filters 
were washed and then exposed to X-ray film to obtain 
a visual pattern of mRNA levels. mRNA levels were 
quantitated using a Packard Instant Imager electronic 
autoradiography imaging system. To control for vari- 
ability in sample handling, values obtained were nor- 
malized to the amount of 28s ribosomal RNA in each 
lane, as assayed with a "P-end-labeled oligonucleotide 
(20) specific for bases 2673-2692 and 3361-3383 of the 
published sequence (21). 
Measurement of cholesterol synthesis rates in vivo 
A detailed description of this methodology and its 
theoretical basis have been presented (6, 22, 23). Sys- 
tematically injected ["HI water rapidly equilibrates with 
the body pool of water. The biosynthetic pathway be- 
tween acetate (primarily derived from glycolysis and p- 
oxidation) and cholesterol involves addition of hydro- 
gens equivalent to 11 moles of water (22). After injec- 
tion of labeled water, the metabolic intermediates of 
cholesterol synthesis rapidly approach a steady-state of 
specific radioactivity with respect to the pool of body 
water. Simple calculations, based on the assumption 
that newly synthesized cholesterol will have a specific 
radioactivity 11 times that of body water, allow for deter- 
mination of the actual rate of synthesis of' cholesterol. 
The number of molecules of newly synthesized squa- 
lene present at any given time can also be determined 
with the assumption that half of the water-equilibrated 
protons in cholesterol entered the metabolic pathway 
at, or prior to, squalene formation. 
Rats exposed to tellurium for 1,3, or 5 days and their 
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age-matched controls were injected intraperitoneally 
with ['Hlwater (100 mCi/ml; ICN Radiochemicals, Ir- 
vine, CA) at a dosage level of 0.5-1.0 mCi/g body 
weight. After a 2-h labeling period, rats were killed and 
a blood sample was collected to obtain serum for deter- 
mination of specific radioactivity of the body water pool. 
Sciatic nerves and livers were removed and lipids were 
extracted from these tissues by a modification (24) of 
the method of Folch, Lees, and Sloane Stanley (25). 
Aliquot. of these lipid extracts were saponified with 
methanolic KOH, and sterols were separated from the 
other nonsaponifiable lipids by reverse-phase HPLC us 
ing a C18 column. The mass of free cholesterol and ra- 
dioactivity associated with cholesterol were determined, 
and the absolute rate of cholesterol synthesis was calcu- 
lated from these data and the specific radioactivity of 
the body water pool. Appropriate controls to account 
for the time needed for cholesterol pathway intermedi- 
ates to equilibrate with body water were included (see 
ref. 6 for details). 
RESULTS 
mRNA expression in liver and sciatic nerve 
After the first day of weaning, .there was a significant 
decline in mRNA expression for HMGCoA reductase 
in livers of control animals (the considerable upregula- 
tion of this message when animals are weaned from c h e  
lesterol-rich milk onto lowcholesterol rat chow has al- 
ready taken place during the first 24 h and is not a factor 
in these experiment.). In contrast, if upon weaning rat. 
are administered tellurium, the resulting inhibition of 
cholesterol synthesis leads to upregulation of mRNA 
expression for HMGCoA reductase (maximal increase 
about 6-fold over controls after 3 days of tellurium; Fig. 
1 and Fig. 2). mRNA expression for squalene epoxidase, 
the eni-yme inhibited by tellurium, was also upregu- 
lated, with a virtually identical temporal pattern (Figs. 
1 and 2). After about 3 weeks of recovery from tellurium 
exposure (30 day time point), mRNA levels for both 
enzymes had returned to control levels. 
The temporal pattern of mRNA expression for HMG 
CoA reductase in sciatic nerves of control animals re- 
sembled liver in that there was a gradual decrease fol- 
lowing weaning (Figs. 1 and 2). However, the response 
to tellurium exposure was very different in sciatic nerve. 
There was a moderate (approx. 1 ..ifold) initial upregu- 
lation after 1 day of tellurium exposure, but this was 
followed by a marked down-regulation. After tellurium 
exposure was terminated, there was a gradual return to 
control levels. As in liver, temporal changes in steady- 
state mRNA levels for squalene epoxidase were parallel 
to those for HMGCoA reductase. Except for the initial 
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Flg. 1. Northern hlot analysis of  steadv state mRNA levels in liver 
and sciatic nerves of rats exposed to tellurium. Tout RNA fractions 
(5 pg/lane) were separated on O.S% denaturing agarose gels. trans- 
ferred to nylon filters, and hybridized with "P-labrled cDNA probes 
specific for either HMCXoA reductase, squalene epoxirlase, or my- 
elin P,, protein (sciatic nerve only). as describcd in Experimental Pro- 
crdrires. Times indicated are days after beginning a 74ay exposlire 
of 2o-dav-old rats to a diet containing I..5''{, tellurium. Arrowheads 
indicate the positions of the 18s and 2RS rRNA suhuniw. 
upregulation seen after 1 day of tellurium exposure, 
changes in mRNA expression for these two cholesterol 
biosynthetic enzymes in sciatic nerve were similar to 
those seen for Po. the major protein of PNS myelin (Fig. 
2), and for other myelin proteins (1 1, 26). 
Both squalene epoxidase and HMGCoA reducme 
were also down-regulated distal to a nerve transection 
(Fig. 3). In these nerve segments, there is axonal degen- 
eration with accompanying secondary demyelination, 
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Fig. 2. Temporal changes in steady-state mRNA levels in liver (upper panel) and sciatic newe (lower panel) 
for H M G C o A  reductase, squalene epoxidase, and myelin P,, protein (sciatic nerve only) after exposure of 
developing rats to tellurium. After hybridization of sciatic nerve and liver RNA samples with "P-labeled cDNA 
probes, radioactivity in each lane was quantitated using an electronic autoradiography imaging system. Values 
obtained were normalized to a constant amount of ribosomal RNA in each lane, as described in Experimental 
Procedures. Data are means 2 SEM for 3-4 separate sets of samples, each consisting of 4-6 animals for each 
time point. Te, tellurium; Con, control; HMGCoAR, H M G C o A  reductase; SOX, squalene epoxidase. 
and myelin-producing Schwann cells revert to a more 
primitive nonmyelinating phenotype (see refs. 27, 28 
for details). The pattern of down-regulation for squa- 
lene epoxidase and HMGCoA reductase was similar to 
that seen for P,, protein, although perhaps not quite as 
severe for the former, presumably because some choles- 
terol synthesis is required for basal maintenance of cells 
remaining in the nerve. 
In vivo cholesterol synthesis in liver and sciatic nerve 
Tellurium-induced alterations in mRNA expression 
for HMGCoA reductase and squalene epoxidase in 
Toews et al. 
liver and sciatic nerve were compared to changes in the 
rates of cholesterol synthesis in these tissues. Utilizing 
an experimental design in which rats were systemati- 
cally labeled with ["]water allows for determination of 
the absolute rate of cholesterol biosynthesis in various 
organs and tissues in vivo (22,23) ,  An extension of this 
methodology has been developed to examine the rela- 
tionship between cholesterol biosynthesis and accumu- 
lation of cholesterol during development in various tis- 
sues, including sciatic nerve (6) and brain (29). 
Cholesterol synthesis in liver was initially inhibited by 
tellurium exposure (50% inhibition after 1 day), but 
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Fig. 3. Temporal changes in steady-state nlRNA levels for HMGCoA 
reductase, squalene epoxidase, arid myelin P,, protein in distal stumps 
of  transected sciatic nerves. Data were analyzed as derailed in legends 
to Figs. 1 antl 2. V~lues are means of  two separate set5 of samples, each 
consisting o f  5-6 nerve stuinps. See legend t o  Fig. 2 for ahbreviations. 
by 5 days after beginning exposure, synthesis levels had 
increased to slightly above normal (Fig. 4, upper 
panel). Cholesterol synthesis in sciatic nerve was also 
inhibited after 1 day of tellurium exposure (56% of con- 
trol). In contrast to liver, however, the rate of synthesis 
remained severely depressed (13% of control after both 
3 and 5 days of tellurium exposure; Fig. 4, lower panel). 
Additional insight into regulation of the cholesterol 
synthesis pathway is available from analysis of the incor- 
poration of label into squalene (intermediate immedi- 
ately above the tellurium-induced block) and choles- 
terol. Taken together, these are indicative of the totdl 
amount of intermediates committed to the sterol bio- 
synthesis pathway, and are a measure of the flux of' in- 
termediates through HMGCoA reductase (there are no 
other pools of intermediates large enough to contain 
significant amounts of label). In liver, tellurium expo- 
sure greatly enhanced flux of precursors committed to 
this pathway (over 8-fold after 5 days of tellurium expo- 
sure; Fig. 5, upper panel). This indicates a compensa- 
tory up-regulation of the cholesterol synthesis pathway 
in response to the tellurium insult. Because of the block 
in squalene epoxidase, there was a marked increase in 
liver squalene levels resulting from this up-regulation 
(Table 1 ) .  We assume that this pileup of precursor 




o,3 1 f, SCIATIC NERVE 
I *  I 1  I 
0.2 - 
1 3 5 
Days after beginning Te exposure 
Fig. 4. (:holesterol synthesis i n  liver antl sciatic nei-i'es ofconttol I itts 
and rats cxposed to tehrium. Rats were injected intraperitoiic;tllv 
with ['Hlwater and 2 ti later they were killed and sciatic nemes and 
a portion of the liver were renroved. h sample of scrim1 \vas also o b  
lained for calculation of  the specific radioactivity of body watrr. lipids 
were extracted from the tissue samples and cholesterol and other me- 
tabolites separated by HPLC and quantitated as described in  Experi- 
mental Procedures. The absolute rate olcholestrrol synthesis w a s  cal- 
culated from radioactivity in cholesterol and thc specific radioacti\ity 
of body water. Times are days after brginning exposure of  weanling 
rats to a diet containing 1.5% telliiriuin, and values ate the I I I C ~ I I ~ S  
of results rrom two separate sets of  animals. Error hars show avrt-;~gr 
deviations of individual valrics trom thc mean. 
bition of the squalene epoxidase step by tellurium. I n  
contrast to liver, the combined synthesis of cholesterol 
and squalene in sciatic nerve was only slightly increased 
(0.6-fold) after 3 and 5 days of tellurium (Fig. .5, lower 
panel). This relatively moderate increase in flux of pre- 
cursors committed to sterol synthesis is not sufficient t o  
compensate for the inhibition of squalene epoxidase in 
sciatic nerve. 
Relative response of liver and sciatic nerve 
to tellurium 
The response of liver to tellurium challenge included 
an almost 4fold elevation in levels of mRNA for HMG 
CoA reductase after 3 and 5 days of tellurium exposure 
(see Fig. 2 ) .  This is reflected in an &fold increase in 
flux through the cholesterol synthesis pathway (Fig. 5 ) ,  
indicating that translational and posttranslational 
mechanisms may account for up to half of the increase 
in activity of HMGCoA reductase. The situation in sci- 
atic nerve was similar in that, although the actual 
amount of message for HMGCoA reductase was de- 
creased to about half of control levels at 3 and 5 days 
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Fig. 5. Synthesis of squalene plus cholesterol in liver and sciatic 
nerve. The combined synthesis of squalene (intermediate immedi- 
ately above the tellurium-induced block) plus cholesterol is indicative 
of the total amount of intermediates committed to the sterol biosyn- 
thesis pathway, and provides a measure of the flux of intermediates 
through HMGCoA reductase. Levels of synthesis were calculated as 
described in the legend to Fig. 4. Values are means of two separate 
sets of animals, and times are days after beginning exposure to a diet 
containing 1.5% tellurium. Error bars show average deviations ofindi- 
vidual values from the mean. 
(see Fig. 2), translational and posttranslational activity 
increased (about 3-fold) so that flux through the path- 
way was actually somewhat increased (Fig. 5 ) .  
In addition to analyses of tellurium-induced pertur- 
bations, our data allow for some comparisons of choles- 
terol synthesis in liver and sciatic nerve of control ani- 
TABLE 1.  Squalene accumulation in liver and sciatic nerve of rats 
exposed to tellurium 
Liver Sciatic Nerve 
Te" 
Exwsure Cmntrol Te Canirol Te 
days nmol/mg tissszce 
mals. The concentration of total cellular RNA is very 
different in these two tissues (0.97 2 0.04 and 6.2 2 0.8 
pg/mg tissue for 21day sciatic nerve and liver, respec- 
tively). This &fold difference presumably reflects the 
role of liver in the synthesis and export of a vast variety 
of proteins. The ratio of HMGCoA reductase mRNA to 
total cellular RNA is about %fold greater in sciatic nerve 
than in liver (calculated from experiments in which 
samples from both tissues were hybridized on the same 
filter, thus controlling for any differences in probe spe- 
cific radioactivity and other hybridization variables). 
These data allow for comparison of levels of cholesterol 
synthesis in control animals as a function of mRNA lev- 
els for HMGCoA reductase. Cholesterol synthesis per 
unit of HMGCoA reductase mRNA was approximately 
3 times greater in control sciatic nerve than in liver, sug- 
gestive of greater reserve capacity for cholesterol synthe- 
sis by liver. 
DISCUSSION 
Exposure to dietary tellurium results in a rapid, 
highly specific inhibition of squalene epoxidase in all 
tissues (3, 4). Inhibition of this obligate enzyme in the 
cholesterol biosynthesis pathway results in decreased 
sterol production. In liver, this intracellular sterol defi- 
cit leads to upregulation of mRNA expression for 
HMGCoA reductase, the major rate-limiting enzyme 
for cholesterol biosynthesis. This is as expected in view 
of the welldocumented regulatory mechanism whereby 
cholesterol feed-back inhibits its own synthesis, acting 
primarily at the level of HMGCoA reductase (see ref. 
8 for review). 
Squalene epoxidase, the enzyme targeted by tellu- 
rium, is also upregulated with a pattern virtually identi- 
cal to that for HMGCoA reductase, indicating a close 
coordinate control of these two enzymes. This is so even 
though HMGCoA reductase catalyzes an early commit- 
ted step in cholesterol biosynthesis, while squalene 
epoxidase catalyzes a reaction following production of 
isoprenoid units required for dolichol, ubiquinone, and 
isopentyl tRNA synthesis, and for polyprenylation of 
p21" and some GTP binding proteins (8,30,31). Stud- 
ies examining regulation of squalene epoxidase mRNA 
expression (32) and enzyme activity (33, 34) suggest it 
also functions as a regulatory enzyme, and our current 
1 0.10 0.76 0.03 0.59 findings, as well as our previous metabolic data (4), 
3 0.08 7.42 0.02 2*62 clearly support this conclusion. 
5 0.03 10.17 0.03 2.83 
A number of recent studies have examined the coor- 
Data are means of two separate animals; individual d u e s  were 
"Days of exposure of 20-day-old rats to a diet containing 1.5% 
dinate transcriptional control of various cholesterol bio- 
synthetic enzymes, including HMGCoA 
HMGCoA synthase, mevalonate kinase, farnesyl di- 
within 10% of the mean. 
tellurium. 
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phosphate synthase, and the LDL-receptor (for reviews, 
see 8, 9, 10). Although the situation is complex, it may 
involve a common mechanism of interaction of one or 
more transacting factors with sterol regulatory element 
(SRE1) sequences found in the promoter regions of 
these genes. It is not known whether the squalene epox- 
idase promoter region also contains this regulatory se- 
quence. 
The up-regulation of mRNA levels for HMGCoA re- 
ductase and squalene epoxidase in liver in response to 
tellurium challenge (about 4fold) accounts for about 
half of the 8-fold increase in incorporation of ['Hlwater 
into cholesterol. Thus, the compensatory responses of 
liver to tellurium challenge occur not only at the level 
of up-regulation of the steady-state mRNA levels, but 
also at the levels of translational and/or  posttransla- 
tional modification. 
Sciatic nerve also responds to tellurium challenge 
with an initial coordinate up-regulation of mRNA ex- 
pression for HMGCoA reductase and squalene epoxi- 
dase. This presumably results from the tellurium- 
induced deficit in intracellular sterols, with the niecha- 
nism being the same as that in liver. In contrast to liver, 
however. after one day the mRNA expression for both 
enzymes is markedly down-regulated, to the same ex- 
tent seen for myelin proteins. We note that even though 
mKNA levels for HMGCoA reductase and squalene 
epoxidase are somewhat down-regulated by 9 days, and 
are only half of control ~7alues by 5 days of tellurium 
exposure, the flux of precursors committed t o  the cho- 
lesterol synthesis pathway (assayed as synthesis of squa- 
lene and cholesterol) is actually stili sonirwhat elevated. 
Despite this up-regulation of material flowing through 
the HMGCoA reductase step, up-regulation is appar- 
ently not sufficient to build up enough squalene t o  
force the required level of cholesterol synthesis. The ra- 
tio of labeled cholesterol to labeled squalene subse- 
quent to tellurium challenge is similar in nerve and liver 
(0.09 i- 0.01, overall mean t SEM for sciatic nen'e and 
liver at 3 and 5 days; calculated from data used to pre- 
pare Fig. 5). Thus, without an %fold or greater increase 
in flux of intermediates through the synthesis pathway 
in sciatic nerve, normal levels of cholesterol biosynthe- 
sis cannot be maintained. 
Why is the cholesterol pathway in sciatic nerve not 
more up-regulated in response to telluriiim challeiige? 
One possibility is a generalized down-regulation in ex- 
pression of myelin components due to the deficit in the 
supply of cholesterol, a major myelin membrane com- 
ponent. If this is the case, there may be an additional 
level of control of cholesterol synthesis in Schwann cells 
related to the program for myelination. (:holesterol is 
the major lipid component of myelin, accounting for 
about 30% of the total lipid dry weight (35), and virtu- 
ally all of the cholesterol synthcsized in these rapidly 
myelinating Schwann cells is destined for myelin assern- 
bly. It seems reasonable that some mechanism might be 
operational to coordinate the supply of cholesterol wi th  
that of other required myelin lipids and the myelin pro- 
teins. The parallel down-regulation of both H.M(X:oiZ 
reductase and squalene epoxidase with myelin protein 
gene expression in degenerating stunips of tl-ansrcted 
nei-ves further supports such "inyeliii-specilic" coordi- 
nate regulation in sciatic nene .  
An explanation alternative to that proposed above is 
that the down-regulation of cholesterol synthesis in 
Schwann cells results from increased intracellular Irvels 
of sterols derived from degenerating myelin. However, 
in  situ hybridization experiments examining PI, expres- 
sion during tellurium exposure have shown that myelin 
synthesis is down-regulated in all rriyeliriatiiig Schwann 
cells, and not -just in  those undergoing demyelination 
(36). Thus, in sciatic iiei-w, the initial up-regulation of' 
the cholesterol synthesis pathway due to sterol depriva- 
tion is countered by an overriding down-regulation CY)- 
ordiiiated with down-regulation of the program of niy- 
elin assembly. 
The very marked differences in the response of liver 
arid sciatic nerve to the tellurium-induced inhihition of' 
cholesterol synthesis suggest that in sciatic i i e i~e ,  the 
entire cholesterol biosynthesis pathway is regulatcd in 
parallel with the synthesis of other components re- 
quired for myelin (PI, and other myelin proteins). This 
coordinate regulation may involve a common control- 
ler element that coordinates inKNA expression for a l l  
required myelin lipid and protein components (for rc- 
view, see 37, 3 8 ) ,  and fLirt.her studies will be needed t o  
determine whether genes for synthesis of myelin lipids 
contain regulatory sequences i n  common with thosc. of 
myelin proteins.a 
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